Printer Friendly
The Free Library
14,529,797 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

St. Paul Pharmaceutical Announces Appointment of CEO.


LOS ANGELES -- St. Paul Pharmaceutical, a pending merger partner with WENR Corp. (OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
:WNRC) (wenr.net), announced today that it named Henry Smith, Ph.D., as CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of St. Paul Pharmaceutical Corp.

Dr. Smith has directed diverse teams of Medical, Scientific and Marketing personnel within both large and small companies. He has over 30 years management experience in all aspects of company operations, from research scientist to CEO. Dr. Smith has set up and registered several laboratories with the FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
. Also, he developed SOP and GMP GMP (guanosine monophosphate): see guanine.  protocols for reference laboratories and a medical device manufacturing facility. Furthermore, he obtained 510(k) registration with the FDA and Notice of Compliance with HPB (Canada) for diagnostic assays.

He is an expert in developing various immunodiagnostic immunodiagnostic

pertaining to diagnosis by immune reactions.
 assays and has expertise in determining clinical validity, accuracy, reproducibility, stability, safety and quality control procedures. He has given lectures on research findings to scientists, made sales promotions on company products to medical professionals and investment presentations to stockbrokers.

As President and CEO of Allied Biotechnology International, Inc., Dr. Smith's Responsibilities involved all aspects of running a publicly held biotechnology company. Products under development included a variety of OTC diagnostic assays and a water purification system. Previously, as Chief Operations Officer of Specialty Medical Industries, Inc., he did hands-on research to develop a wide variety of diagnostic assays and a matched multifunction spectrophotometer spectrophotometer, instrument for measuring and comparing the intensities of common spectral lines in the spectra of two different sources of light. See photometry; spectroscope; spectrum. .

Dr. Smith earned a Ph.D. in Immunology from the University of Leeds Organisation
Faculties
The various schools, institutes and centres of the University are arranged into nine faculties, each with a dean, pro-deans and central functions:
  • Arts
  • Biological Sciences
  • Business
  • Education, Social Sciences and Law
 School of Medicine, England. His thesis was entitled "Immunological Phenomena and Cancer." He earned a B.Sc. (Honors) in General Science University of London For most practical purposes, ranging from admission of students to negotiating funding from the government, the 19 constituent colleges are treated as individual universities. Within the university federation they are known as Recognised Bodies , England.

St. Paul Pharmaceutical is a manufacturer and distributor of pharmaceuticals with locations in Viet Nam, Canada and California. Recently, the Company has signed a letter of intent to merge with WENR Corp. Both St. Paul and WENR Corp. are working towards an anticipated completion of the merger in October.

WENR Corporation is a holding company that acquires technology and technology companies. It provides senior management assistance for product and market development and secures working capital.

The foregoing contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Such forward-looking statements involve certain risks and uncertainties. The actual results may differ materially from such forward-looking statements. The company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results (expressed or implied) will not be realized.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 14, 2005
Words:406
Previous Article:Lions Gate Entertainment Makes Unsolicited Proposal to Image Entertainment.
Next Article:UltraCade Technologies Delivers Fruit Express With Proven Redemption Game Play; Broadens Company Focus to Offer Traditional Machines to the Family...



Related Articles
ICOS Board Appoints Paul Clark New CEO and President.
Sprout Group Names Paul Sekhri as Partner.
Martin Hudson Named CEO of The St. Paul at Lloyd's.
Agency needs school supplies.(Schools)(Students in need are helped by donations to St. Vincent de Paul)
PLIVA Announces New Key Appointments.
Silicon Valley Expert Witness Group Names Dr. Paul Newton as Director of Biotechnology Expert Witness Services.
Paskowitz & Associates Announces Class Action Lawsuit Brought on Behalf of Former Travelers Shareholders.
MedPointe Sets Leadership Succession and Management Realignment Plans into Motion; Paul Edick, Corey Fishman Promoted to CEO, CFO, Respectively;...
Former TheraCom Chairman Robert Dresing Joins SupplyScape Board of Directors; Specialty Pharmacy Innovator Expands Drug Supply Chain Security...
Ballistic Recovery Systems (BRS) Appoints CEO to Board of Directors.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles